A new method for measuring genetic variability within a tumor might one day help doctors identify patients with aggressive cancers that are more likely to resist therapy, according to a study led by researchers now at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
from The Medical News http://ift.tt/1EPdwfw
from The Medical News http://ift.tt/1EPdwfw
No comments:
Post a Comment